Related Experiment Video
Updated: Sep 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
Hypercoagulopathy in Overweight and Obese COVID-19 Patients: a Single-Center Case Series
Azza Sarfraz1,2, Zouina Sarfraz1,3, Aman Siddiqui1,4
1Larkin Health System, South Miami, FL, USA.
Insights
Overweight patients with COVID-19 experienced severe coagulopathy, leading to fatal bleeding and thromboembolism. Understanding this hypercoagulable state is crucial for improving outcomes in obese individuals.
Area of Science:
- Internal Medicine
- Critical Care Medicine
- Pathophysiology
Background:
- Overweight and obesity are prevalent risk factors for severe COVID-19.
- COVID-19 is associated with a prothrombotic state, termed coagulopathy.
- The specific coagulopathic manifestations in obese COVID-19 patients remain under-characterized.
Purpose of the Study:
- To describe the clinical presentation and outcomes of hypercoagulable states in overweight or obese patients with COVID-19.
- To highlight the atypical features of COVID-19-associated coagulopathy in this patient group.
- To emphasize the need for further research into the pathophysiology of coagulopathy in obese COVID-19 patients.
Main Methods:
- A case series of five overweight or obese patients with confirmed COVID-19 was analyzed.
- Coagulation parameters were assessed to identify hypercoagulable states.
- Clinical manifestations, including bleeding and thromboembolism, were documented.
Main Results:
- All five patients exhibited multiple coagulation abnormalities indicative of a hypercoagulable state.
- Manifestations included disseminated intravascular coagulation, venous thromboembolism, gastrointestinal bleeding, and retroperitoneal hematoma.
- All patients required intensive care unit admission and ultimately died.
Conclusions:
- Overweight and obese patients with COVID-19 can present with severe, atypical coagulopathy.
- The observed hypercoagulable state is associated with high mortality.
- Further investigation into the pathophysiology is essential for developing targeted treatments and improving clinical outcomes in this vulnerable population.
Abstract:
A case series is presented of five overweight or obese patients with confirmed coronavirus disease 2019 (COVID-19) in South Miami, Florida, United States. A multitude of coagulation parameters was suggestive of a hypercoagulable state among the hospitalized COVID-19 patients. This article reports various manifestations of hypercoagulable states in overweight and obese patients, such as overt bleeding consistent with disseminated intravascular coagulation, venous thromboembolism, gastrointestinal bleeding as well as retroperitoneal hematoma. All of the required admission to the intensive care unit and subsequently patients died. The characteristics of COVID-19-associated coagulopathy are atypical and warrant a further understanding of the pathophysiology to improve clinical outcomes, specifically in overweight or obese patients.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Obesity
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Bias in Epidemiological Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

